Similar Papers

Paper Title
Journal
Date
Author
Year in review: Liver cancer research in 2022: tumor microenvironment takes the central stage.
Weiting Liao ... Xin Chen
Hepatology communications | VOL. 7
Weiting Liao, et. al.Weiting Liao ... Xin Chen
01 Mar 2023
Immune-Related Adverse Events and Outcomes in Patients with Advanced Non–Small Cell Lung Cancer: A Predictive Marker of Efficacy?
Jordi Remon ... Benjamin Besse
Journal of Thoracic Oncology | VOL. 14
Jordi Remon, et. al.Jordi Remon ... Benjamin Besse
23 Apr 2019
Immunotherapy for NSCLC With Brain Metastases: What Can We Learn From Real-World Data?
Shunichi Kouno ... Shinji Atagi
Journal of Thoracic Oncology | VOL. 14
Shunichi Kouno, et. al.Shunichi Kouno ... Shinji Atagi
21 Jun 2019
Tumor in the Crossfire: Inhibiting TGF-β to Enhance Cancer Immunotherapy.
Nicholas P Tschernia ... James L Gulley
BioDrugs | VOL. 36
Nicholas P Tschernia, et. al.Nicholas P Tschernia ... James L Gulley
01 Mar 2022
View more papers

More From: Pharmacological Research

Paper Title
Journal
Date
Author
Glucagon-like peptide-1 receptor agonists in neurodegenerative diseases: Promises and challenges.
Zhi Dong Zhou ... Eng King Tan
Pharmacological research | VOL. 216
Zhi Dong Zhou, et. al.Zhi Dong Zhou ... Eng King Tan
08 May 2025
Exploring the antitumorigenic properties of agro-food byproducts: A comprehensive scientific review.
M Verrillo ... R Spaccini
Pharmacological research | VOL. 216
M Verrillo, et. al.M Verrillo ... R Spaccini
07 May 2025
Microbiota-derived acetate suppresses sympathetic outflow via olfactory receptor 59 in the rostral ventrolateral medulla.
Jinye Zhang ... Yanming Tian
Pharmacological research | VOL. -
Jinye Zhang, et. al.Jinye Zhang ... Yanming Tian
07 May 2025
Gut microbiota reshapes the TNBC immune microenvironment: Emerging immunotherapeutic strategies.
Mingyao Huang ... Xuexin Li
Pharmacological research | VOL. 215
Mingyao Huang, et. al.Mingyao Huang ... Xuexin Li
01 May 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.